Syntis Bio, Inc.
PrivateLast Round
Series A
Jul 1, 2025
Est. Valuation
$67M
Total Funding Raised
$53.5M
Company Overview
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine's biology for conditions like obesity, diabetes, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syntis Bio, Inc. Comparables
Compare Syntis Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glyscend Therapeutics | 86% | |
| Aphaia Pharma | 76% | |
| Biolexis Therapeutics, Inc. | 75% |
Syntis Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2025 | ||||
| Grant | Jul 1, 2025 |
Key People
Founding team and executive leadership
Syntis Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Cerity Partners Ventures | Series A, Seed |
| Cerberus Ventures | Series A |
| Mansueto Office | Series A |
| Woori Venture Partners Co., Ltd. | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Colorcon Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
David Rosenbaum appointed as Chief Development Officer.
- Mar 3, 2026
Christo Shalish appointed as the new Chief Business Officer.
Recent news
Latest coverage and updates
- is_developingSep 23, 2026
Syntis Bio, Inc. will develop SYNT-101 on Jul 1st '27.
- is_developingSep 2, 2026
Syntis Bio, Inc. is developing pill-based therapies.
Syntis Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access